These include:
is the disease transmissible by the commodity?
could the agent be present in the commodity if derived from a healthy and/or clinically affected animal?
can the predisposing factor be reduced, for example by vaccination?
what is the likelihood that the commodity has been exposed to infection?
has the commodity been obtained in such a way as to reduce the risk, for example deboning?
has the commodity been subjected to a treatment which inactivates the agent?
Appropriate tests and quarantine will reduce the risk.